论文部分内容阅读
洛美沙星(lomefloxacin)是1985年开发的新型喹诺酮类抗菌药,对耳鼻喉科领域感染的致病菌显示出广谱抗菌作用。对其临床效果和安全性进行研究。对象:中耳炎166例,多数为50~70岁病例。其中:急性中耳炎19例,慢性中耳炎16例,慢性中耳炎急性发作131例。鼻窦炎71例,多数为30~60岁病例,其中:急性鼻窦炎21例,慢性鼻窦炎34例,慢性鼻窦炎急性发作16例。给药方法:400~600mg/日,分2~3次口服,多数病例为400mg/日,给药5日以上,禁用激素类药。
Lomefloxacin, a novel quinolone antibacterial drug developed in 1985, shows broad spectrum antibacterial activity against pathogens in the ENT field. To study its clinical effect and safety. Object: otitis media 166 cases, the majority of 50 to 70 years old cases. Of which: 19 cases of acute otitis media, 16 cases of chronic otitis media, 131 cases of acute otitis media. 71 cases of sinusitis, the majority of 30 to 60 years old cases, including: 21 cases of acute sinusitis, chronic sinusitis in 34 cases, 16 cases of acute exacerbation of chronic sinusitis. Dosage: 400 ~ 600mg / day, 2 to 3 times orally, most cases of 400mg / day, for more than 5 days to disable hormonal drugs.